SILCO PHARMACEUTICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.6 BDT | -2.49% |
|
+4.26% | -16.24% |
| Sales 2022 | 559M 4.8M 378M | Sales 2023 | 465M 3.99M 314M | Capitalization | 2.53B 21.73M 1.71B |
|---|---|---|---|---|---|
| Net income 2022 | 84M 721K 56.81M | Net income 2023 | 69M 592K 46.67M | EV / Sales 2022 | 4.79 x |
| Net cash position 2022 | 60.51M 519K 40.93M | Net cash position 2023 | 49.73M 427K 33.64M | EV / Sales 2023 | 5.34 x |
| P/E ratio 2022 |
32.5
x | P/E ratio 2023 |
36.6
x | Employees | 311 |
| Yield 2022 |
1.89% | Yield 2023 |
1.23% | Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.49% | ||
| 1 week | +4.26% | ||
| Current month | +15.29% | ||
| 1 month | +6.52% | ||
| 3 months | -9.68% | ||
| 6 months | -16.24% | ||
| Current year | -16.24% |
1 week
18.50
21.50
1 month
16.2021.50
Current year
16.2023.40
1 year
16.2025.90
3 years
16.2036.10
5 years
16.2037.18
10 years
16.2037.18
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 68 | 24/01/95 | |
| Director of Finance/CFO | - | 31/01/17 | |
| Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Naim Fatema
CHM | Chairman | 70 | 09/11/15 |
| Chief Executive Officer | 68 | 24/01/95 | |
Azizur Rahman
BRD | Director/Board Member | 76 | 24/01/95 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/24 | 19.6 | -2.49% | 130 485 |
| 14/05/24 | 20.1 | -2.90% | 312,356 |
| 13/05/24 | 20.7 | -2.82% | 692,619 |
| 12/05/24 | 21.3 | +8.67% | 987,222 |
| 09/05/24 | 19.6 | +5.95% | 788,802 |
End-of-day quote Dhaka S.E., May 14, 2024
More quotes
Silco Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of antibiotics, analgesics, anti-diabetics, narcotics, antipyratics, anti-inflammatory drugs, antiulcerants and multi medicines. The Companyâs biological products include Viton Syrup, Polylac Syrup, Sliflox Tablet, Vitom-B Tablet, Peristal Tablet, Bactacef Capsule, Bactazim Capsule and others. The Company manufactures products in various dosage forms including tablet, capsule, liquid syrup, dry syrup, pellet, powder and powder suspension.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -16.24% | 17.85M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
- Stock Market
- Equities
- SILCOPHL Stock
